June 3 (Reuters) – The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.52 billion COVID-19 vaccine doses to 146 countries, GAVI data shows.
In December, COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022.
The following tables list countries that have received vaccines under the scheme in alphabetic order:
AFRICA & MIDDLE EAST
COUNTRY LATEST DELIVERY DATE VACCINE TYPE POPULATION TOTAL
DELIVERY DELIVERED
Algeria 3.6 million December 24 J&J 44 million 6.0 million
Angola 801,000 December 25 Pfizer/BioNTech 33 million 14.8 million
Benin 336,000 November 4 J&J 12 million 1.1 million
Botswana 300,000 October 1 AstraZeneca/Oxford 2.5 million 560,460
Burkina Faso 700,000 May 1 Pfizer/BioNTech 21 million 1.8 million
Cameroon 68,600 April 1 AstraZeneca/Oxford 27 million 1.1 million
Cape Verde 200,000 December 7 Pfizer/BioNTech 556,000 324,000
Central 168,300 March 4 N/A 4.8 million 975,000
African
Republic
Chad 828,000 March 24 J&J 16 million 1.0 million
Comoros 90,000 May 8 Pfizer/BioNTech 870,000 360,810
Islands
Congo 168,000 November 15 J&J 5.5 million 470,400
Democratic 349,830 October 21 Pfizer/BioNTech 90 million 2.6 million
Republic of
Congo
Djibouti 151,200 July 17 J&J 988,000 175,200
Egypt 1.5 million April 7 Pfizer/BioNTech 102 million 30.5 million
Eswatini 100,620 October 6 Pfizer/BioNTech 1.1 million 429,420
Equatorial 60,480 June 1 Moderna 1.4 million 60,480
Guinea
Ethiopia 13.1 February 2 J&J 115 million 27.5 million
million
Gabon 101,790 November 1 Pfizer/BioNTech 2.2 million 370,410
Gambia 100,620 March 3 Pfizer/BioNTech 2.4 million 477,420
Ghana 309,600 March 14 AstraZeneca/Oxford 31 million 16.6 million
Guinea 168,000 November 14 J&J 13 million 1.7 million
Guinea-Bissau 136,800 March 25 J&J 2.0 million 496,800
Iran 700,000 January 14 AstraZeneca/Oxford 84 million 5.7 million
Iraq 500,000 August 14 Pfizer/BioNTech 40 million 836,000
Ivory Coast 816,660 January 3 Pfizer/BioNTech 26 million 8.6 million
Jordan 146,400 June 3 AstraZeneca/Oxford 10 million 436,800
Kenya 500,000 May 10 Pfizer/BioNTech 54 million 20.3 million
Lebanon 613,340 December 22 N/A 6.8 million 982,940
Lesotho 169,070 November 19 J&J 2.1 million 644,090
Liberia 583,200 June 1 J&J 5.1 million 2.0 million
Libya 1.2 million December 20 Pfizer/BioNTech 6.9 million 1.9 million
Madagascar 240,000 February 17 J&J 28 million 1.9 million
Malawi 277,080 February 26 AstraZeneca/Oxford 19 million 2.0 million
Mali 907,200 March 24 N/A 20 million 2.8 million
Mauritania 57,330 June 2 Pfizer/BioNTech 4.6 million 2.2 million
Mauritius 203,580 January 12 Pfizer/BioNTech 1.3 million 387,270
Morocco 1.5 million January 29 Pfizer/BioNTech 37 million 2.7 million
Mozambique 1.2 million February 11 AstraZeneca/Oxford 31 million 8.4 million
Namibia 19,890 February 18 Pfizer/BioNTech 2.5 million 512,690
Niger 398,000 February 4 Pfizer/BioNTech 24 million 1.6 million
Nigeria 2.0 million February 7 J&J 206 million 17.2 million
Palestinian 299,520 April 27 Pfizer/BioNTech 4.7 million 1.6 million
Territories
Rwanda 1.1 million January 15 N/A 13 million 3.9 million
Sao Tome and 24,000 March 3 AstraZeneca/Oxford 219,000 24,000
Principe
Senegal 300,000 March 31 AstraZeneca/Oxford 17 million 3.5 million
Seychelles 39,780 December 17 Pfizer/BioNTech 98,460 74,880
Sierra Leone 168,000 November 23 J&J 8.0 million 785,310
Somalia 286,650 May 25 Pfizer/BioNTech 16 million 1.7 million
South Africa 5.6 million July 31 Pfizer/BioNTech 59 million 5.6 million
South Sudan 949,500 April 5 N/A 11 million 1.9 million
Sudan 604,800 February 16 J&J 44 million 3.9 million
Syria 4.0 million January 26 J&J 17 million 5.7 million
Tanzania 2.2 million May 20 J&J 60 million 4.9 million
Togo 633,600 November 25 J&J 8.3 million 3.0 million
Tunisia 599,040 March 31 N/A 12 million 5.4 million
Uganda 2.9 million March 9 J&J 46 million 14.6 million
Yemen 100,800 February 24 AstraZeneca/Oxford 30 million 2.2 million
Zambia 2.6 million May 19 N/A 18 million 4.6 million
Zimbabwe 2.6 million January 19 N/A 15 million 3.5 million
EUROPE
COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL
DELIVERY DATE DELIVERED
Albania 40,800 June 2 AstraZeneca/Oxford 2.8 million 120,000
Armenia 187,200 September 5 AstraZeneca/Oxford 3.0 million 261,200
Azerbaijan 84,000 April 4 AstraZeneca/Oxford 10 million 84,000
Bosnia 32,760 May 10 Pfizer/BioNTech 3.3 million 82,560
Georgia 43,200 March 13 AstraZeneca/Oxford 3.7 million 43,200
Kosovo 515,970 February 10 Pfizer/BioNTech 1.8 million 1.2 million
Moldova 100,620 January 27 Pfizer/BioNTech 2.6 million 744,620
Montenegro 24,000 March 28 AstraZeneca/Oxford 622,000 24,000
North 250,380 February 7 Pfizer/BioNTech 2.1 million 312,780
Macedonia
Serbia 115,200 August 25 AstraZeneca/Oxford 6.9 million 292,800
Ukraine 1.0 million January 19 Pfizer/BioNTech 44 million 8.8 million
ASIA & PACIFIC
COUNTRY LATEST DELIVERY DELIVERY VACCINE TYPE POPULATION TOTAL
DATE DELIVERED
Afghanistan 2.0 million February 2 J&J 39 million 9.0 million
Bangladesh 342,400 February 2 Pfizer/BioNTech 165 million 34.8 million
Bhutan 90,090 April 5 Pfizer/BioNTech 771,612 90,090
Brunei 24,000 April 2 AstraZeneca/Oxford 437,000 24,000
Cambodia 2.0 million May 3 Pfizer/BioNTech 17 million 4.9 million
East Timor 100,620 February 12 Pfizer/BioNTech 1.3 million 494,040
Fiji 50,400 November 18 Moderna 896,000 302,480
Indonesia 3.5 million March 5 Pfizer/BioNTech 274 million 52.3 million
Kiribati 56,000 August 21 AstraZeneca/Oxford 119,000 104,000
Kyrgyzstan 149,760 February 1 Pfizer/BioNTech 6.6 million 800,300
Laos 1.7 million January 26 Pfizer/BioNTech 7.3 million 7.6 million
Malaysia 559,200 September AstraZeneca/Oxford 32 million 1.4 million
17
Maldives 210,600 January 28 Pfizer/BioNTech 541,000 664,540
Mongolia 899,730 October 6 Pfizer/BioNTech 3.3 million 1.3 million
Nauru 7,200 April 2 AstraZeneca/Oxford 10,830 7,200
Nepal 1.5 million March 31 Pfizer/BioNTech 29 million 15.7 million
Pakistan 4.7 million April 12 Pfizer/BioNTech 221 million 43.8 million
Papua New 302,400 August 6 J&J 8.9 million 580,400
Guinea
Philippines 4.0 million March 7 Pfizer/BioNTech 110 million 56.6 million
Samoa 45,630 May 2 Pfizer/BioNTech 198,410 181,630
Solomon 52,650 April 11 N/A 687,000 262,070
Islands
Sri Lanka 820,000 December 20 Pfizer/BioNTech 22 million 5.0 million
Tajikistan 198,900 June 1 Pfizer/BioNTech 9.5 million 6.5 million
Tonga 7,000 February 15 N/A 106,000 67,800
Tuvalu 4,800 April 8 AstraZeneca/Oxford 11,800 4,800
Uzbekistan 2.1 million March 28 Moderna 34 million 19.0 million
Vanuatu 20,400 April 8 Moderna 307,000 44,400
Vietnam 3.5 million April 19 Pfizer/BioNTech 97 million 50.0 million
AMERICAS
COUNTRY LATEST DELIVERY VACCINE TYPE POPULATION TOTAL
DELIVERY DATE DELIVERED
Antigua and 19,200 November 22 N/A 98,000 60,000
Barbuda
Argentina 960,400 October 12 AstraZeneca/Oxford 45 million 3.9 million
Bahamas 57,330 October 18 Pfizer/BioNTech 393,000 124,530
Barbados 14,040 December 16 Pfizer/BioNTech 287,000 114,840
Belize 58,500 October 26 Pfizer/BioNTech 398,000 159,300
Bermuda 9,600 April 6 AstraZeneca/Oxford 64,000 9,600
Bolivia 603,720 April 28 Pfizer/BioNTech 12 million 8.6 million
Brazil 2.0 million September 20 Sinovac 213 million 11.9 million
Chile 331,000 May 20 AstraZeneca/Oxford 19 million 489,400
Colombia 2.3 million March 23 Pfizer/BioNTech 51 million 18.9 million
Costa Rica 200,070 February 28 Pfizer/BioNTech 5.1 million 1.6 million
Dominica 30,240 February 4 Moderna 72,000 133,920
Dominican 184,800 August 27 AstraZeneca/Oxford 11 million 463,200
Republic
Ecuador 1.5 million February 15 Pfizer/BioNTech 18 million 3.8 million
El Salvador 188,370 August 27 Pfizer/BioNTech 6.5 million 3.6 million
Grenada 5,040 March 23 Moderna 113,000 119,670
Guatemala 349,830 June 1 Pfizer/BioNTech 17 million 5.6 million
Guyana 28,800 January 14 J&J 787,000 291,540
Haiti 151,200 February 14 Moderna 11 million 1.1 million
Honduras 250,380 May 5 Pfizer/BioNTech 9.9 million 5.3 million
Jamaica 398,970 March 21 Pfizer/BioNTech 3.0 million 1.9 million
Mexico 4.0 March 4 AstraZeneca/Oxford 129 million 21.3 million
million
Nicaragua 993,600 January 24 J&J 6.6 million 4.7 million
Panama 74,400 September 15 AstraZeneca/Oxford 4.3 million 148,800
Paraguay 466,830 January 24 Pfizer/BioNTech 7.1 million 1.7 million
Peru 1.2 million November 10 Sinopharm 33 million 3.6 million
Saint Kitts and 21,600 April 7 AstraZeneca/Oxford 53,000 21,600
Nevis
Saint Lucia 5,040 March 16 Moderna 184,000 202,470
Saint Vincent 70,200 December 14 Pfizer/BioNTech 111,000 115,800
and the
Grenadines
Suriname 64,800 December 14 AstraZeneca/Oxford 587,000 144,000
Trinidad and 84,000 November 27 Sinopharm 1.4 million 185,200
Tobago
Uruguay 50,400 September 1 AstraZeneca/Oxford 3.5 million 148,800
Venezuela 4.7 million March 14 Sinopharm 28 million 16.8 million
Sources: WHO, UNICEF, GAVI, releases from local authorities
(Compiled by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou, Aleksandra Jasiurska and Elizaveta GladunEditing by Milla Nissi, William Maclean and Mark Potter)
((mailto:antonis.pothitos@thomsonreuters.com ; +48 58 7785 220))
